2015. 4. 24
EverNeuro Pharm와 해외기술이전
: 세레브로리신을 유효성분으로 함유하는 만성외상성뇌병증 예방 또는 치료용 조성물
LICENSE AGREEMENT made by and between [Foundation of Research and Business, Chungnam National Univ.] a corporation organized and existing under [the laws of the Republic of Korea], having an office at [99, Daehak-ro, Yuseong-gu, Daejeon., Korea.] (hereinafter referred to as “LICENSOR”); and [EVER Neuro Pharma (Asia) Ltd.], a corporation organized and existing under [the laws of The Government of the Hong Kong Special Administrative Region of the People’s Republic of China,] having an office at [8/F, Eastwood Center, 5 A Kung Ngam Village Road, Shaukeiwan, Hong Kong] (hereinafter referred to as “LICENSEE”).
